Arthritis News and Research

Latest Arthritis News and Research

WFU awarded $6 million federal grant to further study knee osteoarthritis

A $6 million federal grant, the largest ever awarded to Wake Forest University, will enable health and exercise science researchers to further study knee osteoarthritis and successful treatment measures in community-based settings.

14 Sep 2015

ACR releases two new publications to improve treatment of polymyalgia rheumatica, gout

The American College of Rheumatology (ACR) has released two new publications - recommendations aimed at improving the treatment of patients with polymyalgia rheumatica (PMR), and new classification criteria for gout.

10 Sep 2015

PAH treatments less effective in CTD-associated disease

Patients with connective tissue disease-associated pulmonary arterial hypertension have a poorer response to advanced PAH treatments than those with idiopathic disease, finds a meta-analysis.

9 Sep 2015

Arthritis increases risk of falling into poverty, new research shows

Developing arthritis increases the risk of falling into poverty, especially for women, new research shows. In a study of more than 4,000 Australian adults, females who developed arthritis were 51% more likely to fall into income poverty than nonarthritic women. In men, arthritis was linked with a 22% increased risk.

9 Sep 2015

Warwick Medical School to lead study on the effect of physiotherapy after breast cancer surgery

What is expected to be the biggest UK study on the effect of physiotherapy on women after breast cancer surgery is to be led by Warwick Medical School in partnership with University Hospitals Coventry and Warwickshire NHS Trust.

9 Sep 2015

Physical exercises before and during pregnancy effective in reducing low back, pelvic pain

Pregnancy changes a woman's body in different ways, including the muscles, ligaments, bones, and joints that make up the musculoskeletal system.

4 Sep 2015

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Nektar Therapeutics announced today that it has received a $40 million cash payment under a license agreement with AstraZeneca. The payment was triggered by the first commercial sale of MOVENTIG (naloxegol) in Germany.

1 Sep 2015

Scientists identify new protein that regulates severity of tissue damage caused by RA

Scientists have identified a new protein (C5orf30) which regulates the severity of tissue damage caused by rheumatoid arthritis (RA), an autoimmune disease that causes inflammation, pain, stiffness and damage to the joints of the feet, hips, knees, and hands.

31 Aug 2015

Study: Knee or hip replacement surgery may increase heart attack risk

Contrary to recent reports, Boston-based researchers found that osteoarthritis patients who had total knee or hip joint replacement surgery, known as arthroplasty, were at increased risk of heart attack (myocardial infarction) in the early post-operative period.

31 Aug 2015

Fetal microchimerism could be a subtle and dizzyingly complex puzzle

Parents go to great lengths to ensure the health and well-being of their developing offspring. The favor, however, may not always be returned.

29 Aug 2015

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2015 and updates on its drug development programs.

28 Aug 2015

ACR commends FDA’s draft guidance requiring distinct names for biosimilars, biologic therapies

The American College of Rheumatology (ACR) today praised the Food and Drug Administration (FDA) for issuing draft guidance requiring separate and distinct names for biosimilars and biologic therapies.

28 Aug 2015

Brain scans may help predict patients' response to antipsychotic drug treatment

Investigators at The Feinstein Institute for Medical Research have discovered that brain scans can be used to predict patients' response to antipsychotic drug treatment. The findings are published online in the latest issue of The American Journal of Psychiatry.

28 Aug 2015

Key modifiable Alzheimer’s risk factors pinpointed

A meta-analysis has identified the key modifiable factors associated with an increased or decreased risk of Alzheimer’s disease.

27 Aug 2015

Experts shed light on the exciting field of therapy research for inflammatory diseases

What is happening in the treatment research of the inflammatory autoimmune diseases? Experts from several fields of medicine shed their light on the exciting field of therapy research for the inflammatory (autoimmune) diseases.

27 Aug 2015

TSRI, Janssen collaborate to find universal flu vaccine

Scientists from The Scripps Research Institute and the Janssen Pharmaceutical Companies of Johnson & Johnson have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal flu shots.

24 Aug 2015

Janus collaborates with Roche to develop TLR inhibitor to address several autoimmune diseases

Janus Biotherapeutics today announced that they have entered into a collaboration with Roche for the development of a small molecule toll-like receptor (TLR) inhibitor with the potential to address several autoimmune diseases. TLRs are an important class of proteins that play a key role in the innate immune system.

20 Aug 2015

Scientists develop technique to rejuvenate cells from older osteoarthritis patients

A research team at York has adapted the astonishing capacity of animals such as newts to regenerate lost tissues and organs caused when they have a limb severed.

20 Aug 2015

Programme to tackle superbugs announced by charity

Antibiotic Research UK announced at its Annual General meeting its first research programme to tackle antibiotic resistant bacteria (superbugs).

20 Aug 2015

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS).

20 Aug 2015

Arthritis News and Research

Latest Arthritis News and Research

WFU awarded $6 million federal grant to further study knee osteoarthritis

ACR releases two new publications to improve treatment of polymyalgia rheumatica, gout

PAH treatments less effective in CTD-associated disease

Arthritis increases risk of falling into poverty, new research shows

Warwick Medical School to lead study on the effect of physiotherapy after breast cancer surgery

Physical exercises before and during pregnancy effective in reducing low back, pelvic pain

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Scientists identify new protein that regulates severity of tissue damage caused by RA

Study: Knee or hip replacement surgery may increase heart attack risk

Fetal microchimerism could be a subtle and dizzyingly complex puzzle

Can-Fite BioPharma announces Q2 financial results for 2015, updates drug development programs

ACR commends FDA’s draft guidance requiring distinct names for biosimilars, biologic therapies

Brain scans may help predict patients' response to antipsychotic drug treatment

Key modifiable Alzheimer’s risk factors pinpointed

Experts shed light on the exciting field of therapy research for inflammatory diseases

TSRI, Janssen collaborate to find universal flu vaccine

Janus collaborates with Roche to develop TLR inhibitor to address several autoimmune diseases

Scientists develop technique to rejuvenate cells from older osteoarthritis patients

Programme to tackle superbugs announced by charity

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Arthritis News and Research

Latest Arthritis News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in